Stem cell culture conditions and stability : a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform
(2019) In Regenerative Medicine 14(3). p.243-255- Abstract
Human stem cells have the potential to transform medicine. However, hurdles remain to ensure that manufacturing processes produce safe and effective products. A thorough understanding of the biological processes occurring during manufacture is fundamental to assuring these qualities and thus, their acceptability to regulators and clinicians. Leaders in both human pluripotent and somatic stem cells, were brought together with experts in clinical translation, biomanufacturing and regulation, to discuss key issues in assuring appropriate manufacturing conditions for delivery of effective and safe products from these cell types. This report summarizes the key issues discussed and records consensus reached by delegates and emphasizes the... (More)
Human stem cells have the potential to transform medicine. However, hurdles remain to ensure that manufacturing processes produce safe and effective products. A thorough understanding of the biological processes occurring during manufacture is fundamental to assuring these qualities and thus, their acceptability to regulators and clinicians. Leaders in both human pluripotent and somatic stem cells, were brought together with experts in clinical translation, biomanufacturing and regulation, to discuss key issues in assuring appropriate manufacturing conditions for delivery of effective and safe products from these cell types. This report summarizes the key issues discussed and records consensus reached by delegates and emphasizes the need for accurate language and nomenclature in the scientific discourse around stem cells.
(Less)
- author
- organization
- publishing date
- 2019
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Regenerative Medicine
- volume
- 14
- issue
- 3
- pages
- 243 - 255
- publisher
- Future Medicine Ltd.
- external identifiers
-
- scopus:85064638415
- pmid:30938271
- ISSN
- 1746-0751
- DOI
- 10.2217/rme-2019-0001
- language
- English
- LU publication?
- yes
- id
- 1bbf643f-825e-4c38-a0f0-e7bbdc87c76c
- date added to LUP
- 2019-04-12 13:21:17
- date last changed
- 2024-06-25 10:15:28
@article{1bbf643f-825e-4c38-a0f0-e7bbdc87c76c, abstract = {{<p>Human stem cells have the potential to transform medicine. However, hurdles remain to ensure that manufacturing processes produce safe and effective products. A thorough understanding of the biological processes occurring during manufacture is fundamental to assuring these qualities and thus, their acceptability to regulators and clinicians. Leaders in both human pluripotent and somatic stem cells, were brought together with experts in clinical translation, biomanufacturing and regulation, to discuss key issues in assuring appropriate manufacturing conditions for delivery of effective and safe products from these cell types. This report summarizes the key issues discussed and records consensus reached by delegates and emphasizes the need for accurate language and nomenclature in the scientific discourse around stem cells.</p>}}, author = {{Stacey, Glyn N and Andrews, Peter W and Barbaric, Ivana and Boiers, Charlotta and Chandra, Amit and Cossu, Giulio and Csontos, Lynn and Frith, Thomas Jr and Halliwell, Jason A and Hewitt, Zoe and McCall, Mark and Moore, Harry D and Parmar, Malin and Panico, M Beatrice and Pisupati, Venkat and Shichkin, Valentin P and Stacey, Alison R and Tedesco, Francesco S and Thompson, Oliver and Wagey, Ravenska}}, issn = {{1746-0751}}, language = {{eng}}, number = {{3}}, pages = {{243--255}}, publisher = {{Future Medicine Ltd.}}, series = {{Regenerative Medicine}}, title = {{Stem cell culture conditions and stability : a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform}}, url = {{http://dx.doi.org/10.2217/rme-2019-0001}}, doi = {{10.2217/rme-2019-0001}}, volume = {{14}}, year = {{2019}}, }